All Curated Mutation Sites in HPV

The Virus Mutation(VM) module provides researchers the annotations of reported pathogenic mutations in HPV related to human diseases. The curated VM information includes mutation site, mutation level, virus gene/protein/region, virus-associated disease, genotype/subtype, literature evidence, etc.

Browse Data by Virus Gene/Protein/Region, Disease OR Description

*Please select one option you are interested in, the page will be automatically redirected.

Virus Gene/Protein

Disease

Description

Click the button below to quickly view the viral genes/regions/protein for mutation

Show All

E1^E4

Keyword: Papillomavirus Infections-38037452

ID	PMID	Mutation	Gene/Protein/Region	Encoding Gene/Protein	Disease	Description	Detail
1	38037452	A290A	L1	L1	Papillomavirus Infections	G R S C L	View
2	38037452	A6014C	L1	L1	Papillomavirus Infections	G R S C L	View
3	38037452	A6416G	L1	L1	Papillomavirus Infections	G R S C L	View
4	38037452	A6539G	L1	L1	Papillomavirus Infections	G R S C L	View
5	38037452	A6560G	L1	L1	Papillomavirus Infections	G R S C L	View
6	38037452	C6688A	L1	L1	Papillomavirus Infections	G R S C L	View
7	38037452	G6641A	L1	L1	Papillomavirus Infections	G R S C L	View
8	38037452	I325M	L1	L1	Papillomavirus Infections	G R S C L	View
9	38037452	L150F	L1	L1	Papillomavirus Infections	G R S C L	View
10	38037452	L332L	L1	L1	Papillomavirus Infections	G R S C L	View
11	38037452	R284R	L1	L1	Papillomavirus Infections	G R S C L	View
12	38037452	T375N	L1	L1	Papillomavirus Infections	G R S C L	View
13	38037452	T6434C	L1	L1	Papillomavirus Infections	G R S C L	View
14	38037452	V359V	L1	L1	Papillomavirus Infections	G R S C L	View
15	38037452	A147T	E6	E6	Papillomavirus Infections	G R S C L	View
16	38037452	A388C	E6	E6	Papillomavirus Infections	G R S C L	View
17	38037452	A550C	E6	E6	Papillomavirus Infections	G R S C L	View
18	38037452	A552T	E6	E6	Papillomavirus Infections	G R S C L	View
19	38037452	C187T	E6	E6	Papillomavirus Infections	G R S C L	View
20	38037452	C307T	E6	E6	Papillomavirus Infections	G R S C L	View
21	38037452	C66C	E6	E6	Papillomavirus Infections	G R S C L	View
22	38037452	D86N	E6	E6	Papillomavirus Infections	G R S C L	View
23	38037452	E6Q	E6	E6	Papillomavirus Infections	G R S C L	View
24	38037452	E89K	E6	E6	Papillomavirus Infections	G R S C L	View
25	38037452	G125C	E6	E6	Papillomavirus Infections	G R S C L	View
26	38037452	G365A	E6	E6	Papillomavirus Infections	G R S C L	View
27	38037452	G374N	E6	E6	Papillomavirus Infections	G R S C L	View
28	38037452	G414T	E6	E6	Papillomavirus Infections	G R S C L	View
29	38037452	H13L	E6	E6	Papillomavirus Infections	G R S C L	View
30	38037452	K93N	E6	E6	Papillomavirus Infections	G R S C L	View
31	38037452	Q148P	E6	E6	Papillomavirus Infections	G R S C L	View
32	38037452	R102I	E6	E6	Papillomavirus Infections	G R S C L	View
33	38037452	T147P	E6	E6	Papillomavirus Infections	G R S C L	View
34	38037452	T181C	E6	E6	Papillomavirus Infections	G R S C L	View

Contents
Description

The table shows all curated mutation sites of HPV in each literature

Table Description Column Note

D
The study mentioned a certain treatment method, such as drug resistance caused by mutations.

G
The study mentioned the virus genotype/subtype information.

R
The study mentioned the reference sequence used for comparison, or the original strain of the virus used for site-directed mutagenesis.

S
The study provided sequence information or accession numbers.

L
The study provided the geographic region/country of data origin.

C
The study provided clinical baseline information.

I
The study involved information related to immune.

T
The study involved host target genes.